New technology selects high-affinity proteins

December 01, 2015

Kobe University and the National Institute of Advanced Industrial Science and Technology (AIST) in Japan have developed a technology enabling the selection of proteins with a high affinity for drug target molecules (also proteins) on cell membranes. This discovery will advance research targeting membrane proteins linked to diseases such as cancer, and therefore has potential applications in the development of new biopharmaceuticals. The results of this research were published in the British science journal Scientific Reports on Nov. 19, 2015 at 10am GMT.

This discovery is a result of joint research carried out by Kobe University doctoral student in the Graduate School of Engineering Kaishima Misato, Associate Professor at the Organization of Advanced Science and Technology Ishii Jun, Professor at the Graduate School of Engineering Kondo Akihiko, and Senior Researcher at the AIST Biomedical Research Institute Molecular and Cellular Breeding Research Group Fukuda Nobuo. The defining feature of this research is that by using the yeast signal transduction machinery (1) and the competitive protein binding principle, the group was able to identify mutant proteins (2) that possessed an enhanced ability to bind with membrane proteins.

Membrane proteins play a vital role in controlling the physiological functions of living organisms, and abnormalities in these physiological functions cause diseases such as cancer. This means that molecules which can bind with membrane proteins and regulate physiological functions are potential candidates for drug development. The research team focused on the signal transduction machinery of yeast cells, which share many traits with human cells. Using the knowledge that the localization of signaling molecules on membranes is essential for the growth of yeast cells, they developed a method to select the proteins which bind with 'membrane proteins'. Following this, by artificially creating an intracellular environment in which proteins competed to bind with each other, the research group enabled the selection of mutant proteins with an enhanced affinity for membrane proteins. They demonstrated that this procedure could be applied to human epidermal growth factor receptors (3), a major target molecule for cancer treatment.

By identifying proteins that have a high affinity for membrane proteins, this technology facilitates the creation of new biopharmaceuticals for various drug targets. It could also potentially increase speed and reduce costs in the drug development process.
(1) Signal transduction machinery: transmits information about changes in the surrounding environment to the cell. Controls the destiny and physiological functions of the cell.

(2) Mutant protein: a protein in which the amino acid components are altered.

(3) Epidermal growth factor receptor: in normal tissue this plays a vital role in regulating cell division, replication, and maintenance, but if abnormalities occur in this receptor it can become involved in carcinogenesis and metastasis.

Kobe University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to